Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
28/05 | Mithra Delays AGM Amid Monetization Process | MT |
29/04 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
Sales 2023 | 40.16M 43.56M 3.62B | Sales 2024 * | 43.9M 47.63M 3.96B | Capitalization | 14.93M 16.19M 1.35B |
---|---|---|---|---|---|
Net income 2023 | -174M -189M -15.68B | Net income 2024 * | -55M -59.67M -4.96B | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 336M 27.95B | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 0.34 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | -1.82% | ||
3 months | -58.94% | ||
6 months | -81.12% | ||
Current year | -82.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23/17/23 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 29/23/29 |
Christian Homsy
CHM | Chairman | 65 | 29/23/29 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 20/21/20 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 0.216 | -.--% | 0 |
30/24/30 | 0.216 | -.--% | 0 |
29/24/29 | 0.216 | -.--% | 0 |
28/24/28 | 0.216 | -.--% | 0 |
27/24/27 | 0.216 | -.--% | 0 |
Real-time Euronext Bruxelles, April 26, 2024 at 09:05 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.19M | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
-11.25% | 32.75B | |
+63.50% | 26.47B | |
-20.32% | 14.25B | |
-6.80% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.92% | 9.11B |
- Stock Market
- Equities
- MITRA Stock